Correspondence 0001683168-24-000287 from BIOREGENX, INC. (BRGX) (CIK 0001593184) (BRGX)
BIOREGENX, INC. (BRGX) (CIK 0001593184)
Date: Jan. 16, 2024 · CIK: 0001593184 · Accession: 0001683168-24-000287
AI Filing Summary & Sentiment
File numbers found in text: 000-56345
Referenced dates: January 11, 2024
Show Raw Text
CORRESP
1
filename1.htm
FINDIT, INC.
5051 Peachtree Corners Circle, #200
Peachtree Corners, GA 30092
January 16, 2024
Securities and Exchange Commission
100 F Street, NE
Washington, DC 20549
Re:
Findit, Inc.
Revised Information Statement on Schedule 14C
Filed January 3, 2024
File No. 000-56345
Dear Sir or Madam:
Pursuant to your comment letter dated January 11, 2024, please note
the following:
Revised Information Statement on Schedule 14C -amendment 1
Information About Findit
Management's Discussion and Analysis of Financial Condition, page 56
1.
Please update the management's discussion and analysis of financial condition to include the fiscal year ended December 31, 2022.
Refer to Item 14(c)(1) of Schedule 14A.
Management’s Discussion and analysis of financial condition
has been updated to include the fiscal year ended December 31, 2022.
Information Incorporated by Reference, page 132
2.
We note your response to prior comment 3. Please revise to remove
this section as you appear to be ineligible to incorporate by reference pursuant to Item 14(e)(1) to Schedule 14A.
The section “Information Incorporated by
Reference has been removed.
Sincerely,
Findit, Inc.
/s/Thomas Powers
By: Thomas Powers, CEO